SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial-Reference-Cited by-同舟云学术

SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial

Published:2014-07-04 Issue:1 Volume:15 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Rossi Megan,Johnson David W,Morrison Mark,Pascoe Elaine,Coombes Jeff S,Forbes Josephine M,McWhinney Brett C,Ungerer Jacobus PJ,Dimeski Goce,Campbell Katrina L

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1186/1471-2369-15-106.pdf

Reference79 articles.

1. Austin M, Mellow M, Tierney WM: Fecal microbiota transplantation in the treatment of clostridium difficile infections. Am J Med. in press

2. Meijers BKI, Evenepoel P: The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrol Dial Transplant. 2011, 26: 759-761.

3. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL: Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013, 83: 308-315.

4. Schepers E, Glorieux G, Vanholder R: The Gut: the forgotten organ in Uremia?. Blood Purif. 2010, 29: 130-136.

5. Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, Endo M, Noguchi T, Kadowaki D, Ishima Y, Kotani S, Nakajima M, Kataoka K, Kim-Mitsuyama S, Tanaka M, Fukagawa M, Otagiri M, Maruyama T: p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int. 2013, 83: 582-592.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiota alteration in CKD: From toxicity mechanisms to supplementation;Archives of Renal Diseases and Management;2024-04-18

2. Synbiotics, prebiotics and probiotics for people with chronic kidney disease;Cochrane Database of Systematic Reviews;2023-10-23

3. Canagliflozin protects the cardiovascular system through effects on the gut environment in non-diabetic nephrectomized rats;Clinical and Experimental Nephrology;2023-01-07

4. Association between prevalence of laxative use and history of bone fractures and cardiovascular diseases in patients with chronic kidney disease: the Fukuoka Kidney disease Registry (FKR) study;Clinical and Experimental Nephrology;2022-11-01

5. Probiotics-Supplemented Low-Protein Diet for Microbiota Modulation in Patients with Advanced Chronic Kidney Disease (ProLowCKD): Results from a Placebo-Controlled Randomized Trial;Nutrients;2022-04-14